Introduction {#sec1}
============

Quinazolines and their derivatives are one of the most important nitrogen-containing heterocycles because they often have several biological activities.^[@ref1]^ For example, erlotinib^[@ref2]^ as an anticancer, CCT241533^[@ref3]^ as a potent and selective ATP competitive inhibitor of CHK2, and 2-arylquinazoline **1**([@ref4]) as a potent analgesic agent have been reported ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). Although a variety of synthetic methods of quinazolines have been reported,^[@ref5]^ the development of an efficient synthesis of 2-arylquinazolines has been highly desired because 2-arylquinazoline derivatives have been still well studied, e.g., as potential antiviral compounds^[@ref6]^ and covalent lipid pocket ligands targeting p38a MAPK mutants.^[@ref7]^ Recently, several synthetic methods of 2-arylquinazoline using some transition-metal catalysts have been documented. Gogoi reported Ru(II)-catalyzed C--H activation and annulation reaction via a carbon--carbon triple bond cleavage.^[@ref8]^ Xu and Ji reported the efficient synthesis of 2-arylquinazolin-4-amines via a copper-catalyzed diazidation and ring expansion cascade of 2-arylindoles.^[@ref9]^ Some synthetic methods of 2-arylquinazolines from 2-aminobenzonitrile and its derivatives have been reported. Chen and He reported the synthesis of quinazolines via an iron-catalyzed oxidative amination of N--H ketimines.^[@ref10]^ Chen reported the 2-arylquinazoline synthesis using the palladium-catalyzed three-component tandem reaction of 2-aminobenzonitrile, aldehydes, and arylboronic acids.^[@ref11]^ Xu and co-workers reported the 2-arylquinazoline synthesis by the rhodium(III)-catalyzed cascade \[5 + 1\] annulation/5-exocyclization reaction of amidines with diynes.^[@ref12]^ Jiang reported the copper-catalyzed synthesis of substituted quinazolines from benzonitriles and 2-ethynylanilines via a carbon--carbon bond cleavage using molecular oxygen.^[@ref13]^ Chen reported the synthesis of quinazolines using the palladium-catalyzed tandem reaction of *N*-(2-cyanoaryl)benzamides with arylboronic acids.^[@ref14]^ Synthetic methods using the catalyst except the transition metal have also been developed. Xiao and Deng reported the Lewis acid-catalyzed 2-arylquinazoline formation from *N*′-arylbenzimidamides and paraformaldehyde.^[@ref15]^ Bhanage reported molecular-iodine-catalyzed benzylic sp^3^ C--H bond amination for the synthesis of 2-arylquinazolines from 2-aminobenzaldehydes, 2-aminobenzophenones, and 2-aminobenzyl alcohols.^[@ref16]^

![Examples of Quinazolines Having a Biological Activity](ao-2019-01199f_0001){#sch1}

Titanium(IV) tetrahalides are widely used in carbon--carbon bond-forming reactions, for example, Diels--Alder reactions, Mukaiyama aldol reactions of silyl enol ethers with aldehydes, and carbonyl-ene reactions as a Lewis acid. Furthermore, low-valent titanium halides promote reductive coupling reactions of several carbonyl compounds. Ligands of titanium halides are bromide or chloride in most of these reactions.^[@ref17]^ On the other hand, titanium(IV) tetraiodide (TiI~4~) had been used for the production of high-purity metal titanium. However, its use was rare in organic synthesis. We have focused on a reducing ability, a mild Lewis acidity, and an iodination ability of titanium(IV) tetraiodide and have already reported a variety of reactions such as pinacol coupling reaction, reductive aldol, Mannich-type reactions, Prins reaction, iodo-aldol reaction, and iodo-Mannich reaction.^[@ref18]^ In 2009, we reported the multisubstituted 2-iodopyridine **3** synthesis via iodination--cyclization reactions of cyanoalkenyl-β-ketoesters **2** using TiI~4~ ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}a).^[@ref19]^ In 2017, we also developed an efficient synthetic method for 3-aryl-1-iodoisoquinolines **5** using the TiI~4~-induced cyclizations of cyanoketones **4** ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}b).^[@ref20]^ On the basis of our continuous interest in the TiI~4~-induced cyclizations of cyanocarbonyl compounds, we next envisioned a synthesis of 2-aryl-4-iodoquinazolines **7** via iodination--cyclization reactions of *N*-(2-cyanophenyl)benzamides **6** using TiI~4~ because there are few reports for the useful synthetic methods of 2-aryl-4-iodoquinazolines ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}c).^[@ref21]^ Herein, we report the synthesis of 2-aryl-4-iodoquinazolines **7** via iodination--cyclization reactions of *N*-(2-cyanophenyl)benzamides **6** using TiI~4~ and trimethylsilyl iodide (TMSI). Moreover, to prove the utility of the method, we applied it to the formal synthesis of the potent analgesic agent **1**.

![Titanium Tetraiodide-Induced Cyclization Cycanocarbonyl Compounds for the Synthesis of Nitrogen-Containing Heterocycles](ao-2019-01199f_0002){#sch2}

Results and Discussion {#sec2}
======================

First, we examined the titanium tetraiodide-induced cyclization of *N*-(2-cyanophenyl)benzamide **8** into 2-aryl-4-iodoquinazoline **7a** under similar reaction conditions to those of 3-aryl-1-iodoisoquinolines **5** synthesis reported previously.^[@ref20]^ The desired 2-aryl-4-iodoquinazoline **7a** was not obtained along with the recovered **8** in 54% yield ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}a). When the reaction of *N*-(2-cyanophenyl)benzamide **8** was carried out in the presence of TiI~4~ in 1,2-dichloroethane (DCE) under reflux, the 2-aryl-4-iodoquinazoline **7a** was obtained in 4% yield accompanied by the recovered **8** in 90% yield ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}b). We presumed that a proton at the amide moiety of **8** caused the low yield and the recovery of the starting material **8**. We next examined the reaction of *N*-(2-cyanophenyl)benzamide **6a** having a 4-chlorophenylmethyl substituent as both a convenient protecting group and a leaving group. The yield of **7a** increased slightly to 18% along with the recovered **6a** in 33% yield and 1-chloro-4-(iodomethyl)benzene (**9**) in 27% yield ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}c). Therefore, several reaction conditions were next examined regarding the titanium tetraiodide-induced cyclization of *N*-(2-cyanophenyl)benzamide **6a** to improve the yield of 2-aryl-4-iodoquinazoline **7a** ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}).

![Titanium Tetraiodide-Induced Cyclization of *N*-(2-Cyanophenyl)benzamides into 2-Aryl-4-iodoquinazoline **7a**](ao-2019-01199f_0003){#sch3}

###### Optimization of the Titanium Tetraiodide-Induced Cyclization

![](ao-2019-01199f_0008){#fx16}

  entry   TiI~4~ (equiv)   solvent         additive (equiv)    yield (%)[a](#t1fn1){ref-type="table-fn"}
  ------- ---------------- --------------- ------------------- -------------------------------------------
  1       2.00             DCE             none                18
  2       2.00             toluene         none                22
  3       2.00             xylene          none                17
  4       2.00             chlorobenzene   none                17
  5       2.00             toluene         NaI (2.00)          26
  6       2.00             toluene         KI (2.00)           33
  7       2.00             toluene         I~2~ (2.00)         23
  8       2.00             toluene         Me~4~NI (2.00)      15
  9       2.00             toluene         *n*Bu~4~NI (2.00)   19
  10      2.00             toluene         TMSI (2.00)         62
  11      none             toluene         TMSI (2.00)         0
  12      2.00             toluene         TMSI (1.00)         56
  13      2.00             toluene         TMSI (2.50)         62
  14      2.00             toluene         TMSI (3.00)         67
  15      2.00             toluene         TMSI (3.50)         85
  16      2.00             toluene         TMSI (4.00)         53
  17      1.50             toluene         TMSI (3.50)         80
  18      2.50             toluene         TMSI (3.50)         79

Isolated yields.

Among the solvents tested, toluene was found to be a slightly better solvent (entries 1--4). Effects of several iodide ion sources as an additive were next investigated (entries 5--10). When TMSI was used, the yield increased significantly to 62% (entry 10). When the reaction of **7a** was carried out using TMSI in the absence of TiI~4~, the 2-aryl-4-iodoquinazoline **7a** was not obtained and the *N*-(2-cyanophenyl)benzamide **6a** was recovered in 59% yield accompanied by 1-chloro-4-(iodomethyl)benzene (**9**) in 19% yield (entry 11). Effects of the amounts of TiI~4~ and TMSI were further investigated (entries 12--18). When the cyclization of *N*-(2-cyanophenyl)benzamide **6a** was carried out using TiI~4~ (2.00 equiv) and TMSI (3.50 equiv), the 2-aryl-4-iodoquinazoline **7a** was obtained in 85% yield (entry 15). Finally, the effects of the protecting group at the amide moiety were examined. The reactions of *N*-(2-cyanophenyl)benzamides **10a** and **10b** having benzyl or allyl groups at the amide moiety gave the 2-aryl-4-iodoquinazoline **7a** in 77 and 73% yields, respectively ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}).

![Effects of Protecting Groups](ao-2019-01199f_0004){#sch4}

With the optimized reaction conditions in hand, several *N*-(2-cyanophenyl)benzamides **6** were subjected to the titanium tetraiodide/trimethylsilyl iodide synergistically induced cyclization. [Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"} summarizes the results. The cyclizations of *N*-(2-cyanophenyl)benzamides **6b** (R^1^ = H, R^2^ = 4-F) and **6c** (R^1^ = H, R^2^ = 4-Br) having an electron-withdrawing group afforded the 2-aryl-4-iodoquinazolines **7b** and **7c** in 78 and 67% yields, respectively. The cyclization of *N*-(2-cyanophenyl)benzamide **6d** (R^1^ = R^2^ = H) gave the 2-aryl-4-iodoquinazoline **7d** in 63% yield. The cyclization of *N*-(2-cyanophenyl)benzamide **6e** (R^1^ = H, R^2^ = Me) having an electron-donating group worked well to afford the 2-aryl-4-iodoquinazoline **7e** in 57% yield. The cyclizations of *N*-(2-cyanophenyl)benzamides **6f** (R^1^ = H, R^2^ = 2-Cl) and **6g** (R^1^ = H, R^2^ = 3-Cl) gave the 2-aryl-4-iodoquinazolines **7f** and **7g** in 59 and 61% yields, respectively. The cyclization of *N*-(2-cyanophenyl)benzamide **6h** (R^1^ = H, R^2^ = 3,5-Cl~2~) afforded the *N*-(2-cyanophenyl)benzamide **7h** in 69% yield. The substituents at the aminobenzonitrile moiety R^1^ were next investigated. The cyclizations of *N*-(2-cyanophenyl)benzamides **6i** (R^1^ = Cl, R^2^ = 4-Cl) and **6j** (R^1^ = Cl, R^2^ = H) having an electron-withdrawing group gave the 2-aryl-4-iodoquinazolines **7i** and **7j** in 80 and 71% yields, respectively. The cyclization of *N*-(2-cyanophenyl)benzamide **6k** (R^1^ = Me, R^2^ = 4-Cl) having an electron-donating group afforded the 2-aryl-4-iodoquinazoline **7k** in moderate yield.

![Synthesis of 2-Aryl-4-iodoquinazolines **7**\
Reaction conditions: **6** (0.150 mmol), TiI~4~ (0.300 mmol), TMSI (0.525 mmol), toluene (3.0 mL), reflux, 14 h, under Ar, isolated yields.](ao-2019-01199f_0005){#sch5}

A plausible reaction mechanism for the 2-aryl-4-iodoquinazoline **7** formation is shown in [Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}. First, TiI~4~ would coordinate to the cyano group of the *N*-(4-chlorobenzyl)-*N*-(2-cyanoaryl)benzamide **6** to generate intermediate **11**. The titanium intermediate **12** would be formed via a nucleophilic addition of an iodide ion to the cyano group of intermediate **11**. Subsequent intramolecular cyclization of the titanium intermediate **12** would give the titanium alkoxide intermediate **13**. The titanium alkoxide intermediate **13** would undergo aromatization promoted by TMSI as an additive via the elimination of \[(trimethylsilyl)oxy\]titanium(IV) iodide (**14**) and 1-chloro-4-(iodomethyl)benzene (**9**) to give the 2-aryl-4-iodoquinazoline **7**. Synergetic effect of the titanium alkoxide and TMSI would be crucial for the aromatization. The coordination of the titanium alkoxide to a silyl group would increase a nucleophilicity of an iodide ion and promote the elimination of \[(trimethylsilyl)oxy\]titanium(IV) iodide (**14**). 1-Chloro-4-(iodomethyl)benzene (**9**) as a byproduct is obtained accompanied by 2-aryl-4-iodoquinazolines **7** in every case.

![Possible Reaction Mechanism](ao-2019-01199f_0006){#sch6}

As an application, we examined the formal synthesis of the potent analgesic agent **1**([@ref4]) from 4-iodo-2-phenylquinazoline (**7d**). The S~N~Ar reaction of 2-aryl-4-iodoquinazoline **7d** with ethyl piperidine-4-carboxylate proceeded smoothly to provide the 2-phenylquinazoline **15** in high yield ([Scheme [7](#sch7){ref-type="scheme"}](#sch7){ref-type="scheme"}).

![Formal Synthesis of the Potent Analgesic Agent **1**](ao-2019-01199f_0007){#sch7}

Conclusions {#sec3}
===========

In conclusion, we have developed a synthesis of 2-aryl-4-iodoquinazolines **7** using titanium tetraiodide/trimethylsilyl iodide synergistically induced iodination--cyclization reactions of *N*-(4-chlorobenzyl)-*N*-(2-cyanoaryl)benzamides **6** as a nitrogen source, and the subsequent application to the formal synthesis of the potent analgesic agent **1** has been successfully achieved. The present 2-aryl-4-iodoquinazoline synthesis is an attractive method because *N*-(4-chlorobenzyl)-*N*-(2-cyanoaryl)benzamides **6** as a starting material are readily prepared from the corresponding 2-aminobenzonitrile derivatives in two steps, and furthermore, an iodine substituent can be transformed into other functional groups using S~N~Ar reactions and transition-metal-catalyzed cross-coupling reactions.^[@ref22]^

Experimental Section {#sec4}
====================

General Aspects {#sec4.1}
---------------

Melting point (mp) determinations were performed using a YAMATO MP-21 instrument and are uncorrected. ^1^H NMR and ^13^C NMR spectra were recorded on a JEOL JNM-ECX-400P spectrometer (400 MHz) with tetramethylsilane as an internal standard. Infrared spectra were recorded on a JASCO FT/IR-460 Plus spectrometer. 1,4-Dioxane was distilled from CaH~2~ and stored over sodium. Toluene was predried with CaCl~2~, distilled, and stored over molecular sieves 4 Å. Dimethylformamide was distilled from calcium hydride and stored over molecular sieves 4 Å. Dimethylacetoamide was distilled from KOH and CaO and stored over molecular sieves 4 Å. Pyridine was predried with KOH, distilled from KOH, and stored over KOH. Purification of products was performed by preparative thin layer chromatography (TLC) on silica gel (Wako Gel B-5F) and/or column chromatography on silica gel (Kanto Chemical Co. Inc., Silica Gel 60 N (spherical, neutral)) and recrystallization from ethanol. All reactions were carried out under an argon atmosphere.

### Synthesis of Benzonitrile **16** {#sec4.1.1}

![](ao-2019-01199f_0010){#fx1}

To a 50 mL two-necked round-bottomed flask equipped with a magnetic stirring bar, a rubber septum, and an argon balloon were added 2-aminobenzonitrile (2.00 g, 16.9 mmol), acetic acid (25 mL), and 4-chlorobenzaldehyde (3.09 g, 22.0 mmol). The mixture was stirred for 30 min at room temperature and cooled in an ice bath; then, NaBH~4~ (0.68 g, 17.9 mmol) was added in portions. The resulting mixture was gradually warmed up to room temperature during 13.5 h. Water (20 mL) was added to quench the reaction. The mixture was extracted with ethyl acetate (100 mL). The combined organic layers were dried over sodium sulfate. The solvents were evaporated in vacuo, and then the residue was purified by column chromatography on silica gel (hexane/ethyl acetate = 40:1) to give the *N*-(2-cyanophenyl)benzamide **16** (3.14 g, 77%) as a white solid.

### 2-((4-Chlorobenzyl)amino)benzonitrile (**16**) {#sec4.1.2}

Mp = 118--120 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 7.41 (dd, *J* = 1.4, 7.8 Hz, 1H), 7.34--7.25 (m, 5H), 6.69 (t, *J* = 7.3 Hz, 1H), 6.56 (d, *J* = 8.2 Hz, 1H), 5.06 (brs, 1H), 4.41 (d, *J* = 6.0 Hz, 2H); ^13^C NMR (100 MHz, CDCl~3~) δ 149.8, 136.3, 134.2, 133.3, 132.7, 129.0, 128.3, 117.7, 117.1, 111.0, 96.1, 46.7; IR (KBr) 3388, 3046, 2947, 2889, 2848, 2210, 1607, 1578, 1516, 1403, 1326, 1291, 1272, 1164, 1091, 1012, 819, 746 cm^--1^; HRMS (EI): Calculated for C~14~H~11~ClN~2~ (M)^+^ 242.0611, found 242.0603.

### Synthesis of Benzonitrile **17** {#sec4.1.3}

![](ao-2019-01199f_0011){#fx2}

To a 50 mL two-necked round-bottomed flask equipped with a magnetic stirring bar, a rubber septum, and an argon balloon were added 2-amino-5-chlorobenzonitrile (2.50 g, 16.4 mmol), acetic acid (25 mL), and 4-chlorobenzaldehyde (2.99 g, 21.3 mmol). The mixture was stirred for 30 min at room temperature and cooled in an ice bath; then, NaBH~4~ (0.66 g, 17.4 mmol) was added in portions. The resulting mixture was gradually warmed up to room temperature during 14 h. Water (30 mL) was added to quench the reaction. The mixture was extracted with ethyl acetate (200 mL). The combined organic layers were dried over sodium sulfate. The solvents were evaporated in vacuo, and then the residue was purified by recrystallization from ethanol to give the *N*-(2-cyanophenyl)benzamide **17** (3.29 g, 72%) as a white solid.

### 5-Chloro-2-((4-chlorobenzyl)amino)benzonitrile (**17**) {#sec4.1.4}

Mp = 156--159 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 7.37--7.24 (m, 6H), 6.52--6.49 (m, 1H), 5.08 (brs, 1H), 4.40 (d, *J* = 6.0 Hz, 2H); ^13^C NMR (100 MHz, CDCl~3~) δ 148.4, 135.7, 134.4, 133.6, 131.7, 129.1, 128.3, 121.6, 116.5, 112.4, 97.1, 46.9; IR (KBr) 3410, 3066, 2958, 2907, 2871, 2217, 1605, 1571, 1506, 1447, 1407, 1359, 1321, 1296, 1272, 1175, 1139, 1092, 1012, 886, 828, 718 cm^--1^; HRMS (EI): Calcd for C~14~H~10~Cl~2~N~2~ (M)^+^ 276.0221, found 276.0224.

*N*-(2-Cyanophenyl)benzamide **8** was prepared according to the literature.^[@ref23]^

### Synthesis of *N*-(2-Cyanophenyl)benzamide **6a** {#sec4.1.5}

![](ao-2019-01199f_0012){#fx3}

In a 100 mL two-necked round-bottomed flask equipped with a magnetic stirring bar, a rubber septum, a Dimroth condenser, and an argon balloon was placed benzonitrile **16** (2.21 g, 9.11 mmol) in pyridine (5 mL) at room temperature, and to it was added 4-chlorobenzoyl chloride (1.64 g, 9.37 mmol). The reaction mixture was stirred at 80 °C for 14 h and then cooled down to room temperature. The reaction mixture was diluted with dichloromethane (30 mL) and washed with 2 M HCl (20 mL × 3) and saturated aqueous NaHCO~3~ solution (20 mL). The organic layers were dried over sodium sulfate and filtered. The solvents were evaporated in vacuo, and then the residue was purified by recrystallization from ethanol to give *N*-(2-cyanophenyl)benzamide **6a** (2.19 g, 64%) as a white solid.

### 4-Chloro-*N*-(4-chlorobenzyl)-*N*-(2-cyanophenyl)benzamide (**6a**) {#sec4.1.6}

Mp = 144--145 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 7.51 (d, *J* = 7.8 Hz, 1H), 7.46--7.42 (m, 1H), 7.31--7.15 (m, 9H), 6.99 (d, *J* = 7.8 Hz, 1H), 5.33 (brs, 1H), 4.93 (brs, 1H); ^13^C NMR (100 MHz, CDCl~3~) δ 169.2, 144.9, 136.4, 134.3, 133.9, 133.8, 133.7, 133.3, 130.5, 130.0, 130.0, 128.7, 128.2, 128.1, 116.0, 112.8, 52.9; IR (KBr) 3065, 2985, 2940, 2234, 1644, 1591, 1488, 1380, 1311, 1215, 1178, 1145, 1087, 1012, 975, 867, 841, 796, 770, 754, 733 cm^--1^; HRMS (EI): Calcd for C~21~H~14~Cl~2~N~2~O (M)^+^ 380.0483, found 380.0499.

### Synthesis of *N*-(2-Cyanophenyl)benzamide **6b** {#sec4.1.7}

![](ao-2019-01199f_0013){#fx4}

In a 100 mL two-necked round-bottomed flask equipped with a magnetic stirring bar, a rubber septum, a Dimroth condenser, and an argon balloon was placed benzonitrile **16** (500 mg, 2.06 mmol) in pyridine (20 mL) at room temperature, and to it was added 4-fluorobenzoyl chloride (336 mg g, 2.12 mmol). The reaction mixture was stirred at 80 °C for 20 h and then cooled down to room temperature. Water (20 mL) was added to quench the reaction. The mixture was extracted with ethyl acetate (80 mL). The combined organic layers were dried over sodium sulfate. The solvents were evaporated in vacuo, and then the residue was purified by column chromatography on silica gel (hexane/ethyl acetate = 10:1) and then by recrystallization from ethanol to give *N*-(2-cyanophenyl)benzamide **6b** (519 mg, 69%) as a white solid.

### *N*-(4-Chlorobenzyl)-*N*-(2-cyanophenyl)-4-fluorobenzamide (**6b**) {#sec4.1.8}

Mp = 109--110 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 7.51 (d, *J* = 7.6 Hz, 1H), 7.46--7.41 (m, 1H), 7.39--7.36 (m, 2H), 7.29--7.27 (m, 1H), 7.23--7.20 (m, 4H), 7.00 (d, *J* = 7.8 Hz, 1H), 6.90--6.84 (m, 2H), 5.34 (brs, 1H), 4.94 (brs, 1H); ^13^C NMR (100 MHz, CDCl~3~) δ 169.3, 163.5 (d, *J* = 252 Hz), 145.1, 134.4, 133.9, 133.8, 133.6, 131.0 (d, *J* = 3.8 Hz), 130.9 (d, *J* = 8.6 Hz), 130.5, 130.0, 128.7, 127.9, 116.1, 115.1 (d, *J* = 22.0 Hz), 112.8, 52.9; IR (KBr) 3074, 2942, 2231, 1663, 1604, 1508, 1489, 1454, 1370, 1311, 1267, 1238, 1143, 1086, 1016, 969, 841, 789, 756 cm^--1^; HRMS (EI): Calcd for C~21~H~14~ClFN~2~O (M)^+^ 364.0779, found 364.0784.

### Synthesis of *N*-(2-Cyanophenyl)benzamide **6c** {#sec4.1.9}

![](ao-2019-01199f_0014){#fx5}

In a 100 mL two-necked round-bottomed flask equipped with a magnetic stirring bar, a rubber septum, a Dimroth condenser, and an argon balloon was placed benzonitrile **16** (1.20 g, 4.94 mmol) in pyridine (20 mL) at room temperature, and to it was added 4-fluorobenzoyl chloride (1.41 g, 6.43 mmol). The reaction mixture was stirred at 80 °C for 16 h and then cooled down to room temperature. Water (20 mL) was added to quench the reaction. The mixture was extracted with ethyl acetate (80 mL). The combined organic layers were dried over sodium sulfate. The solvents were evaporated in vacuo, and then the residue was purified by column chromatography on silica gel (hexane/ethyl acetate = 10:1) and then by recrystallization from ethanol to give *N*-(2-cyanophenyl)benzamide **6c** (1.47 g, 70%) as a white solid.

### 4-Bromo-*N*-(4-chlorobenzyl)-*N*-(2-cyanophenyl)benzamide (**6c**) {#sec4.1.10}

Mp = 155--157 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 7.53 (d, *J* = 7.8 Hz, 1H), 7.45--7.41 (m, 1H), 7.34--7.28 (m, 3H), 7.25--7.19 (m, 6H), 6.97 (d, *J* = 7.8 Hz, 1H), 5.35 (brs, 1H), 4.91 (brs, 1H); ^13^C NMR (100 MHz, CDCl~3~) δ 169.3, 144.8, 134.3, 133.9, 133.8, 133.7, 136.8, 131.2, 130.5, 130.1, 130.0, 128.7, 128.1, 124.8, 116.0, 112.8, 52.9; IR (KBr) 3064, 2940, 2234, 1636, 1591, 1489, 1447, 1396, 1312, 1215, 1179, 1158, 1144, 1090, 1069, 1008, 974, 866, 839, 796, 769, 754, 727 cm^--1^; HRMS (EI): Calcd for C~21~H~14~BrClN~2~O (M)^+^ 423.9978, found 423.9968.

### Synthesis of *N*-(2-Cyanophenyl)benzamide **6d** {#sec4.1.11}

![](ao-2019-01199f_0015){#fx6}

In a 50 mL two-necked round-bottomed flask equipped with a magnetic stirring bar, a rubber septum, a Dimroth condenser, and an argon balloon was placed benzonitrile **16** (1.00 g, 4.12 mmol) in pyridine (20 mL) at room temperature, and to it was added benzoyl chloride (666 mg, 4.74 mmol). The reaction mixture was stirred at 80 °C for 40 h and then cooled down to room temperature. Water (20 mL) was added to quench the reaction. The mixture was extracted with ethyl acetate (80 mL). The combined organic layers were dried over sodium sulfate. The solvents were evaporated in vacuo, and then the residue was purified by column chromatography on silica gel (hexane/ethyl acetate = 10:1) and then by recrystallization from ethanol to give *N*-(2-cyanophenyl)benzamide **6d** (1.08 g, 65%) as a white solid.

### *N*-(4-Chlorobenzyl)-*N*-(2-cyanophenyl)benzamide (**6d**) {#sec4.1.12}

Mp = 149--150 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 7.50 (d, *J* = 7.3 Hz, 1H), 7.41--7.36 (m, 3H), 7.22--7.18 (m, 8H), 6.96 (d, *J* = 8.2 Hz, 1H), 5.41 (brs, 1H), 4.90 (brs, 1H); ^13^C NMR (100 MHz, CDCl~3~) δ 170.4, 145.2, 135.0, 134.6, 133.8, 133.7, 133.5, 130.5, 130.3, 130.2, 128.7, 128.4, 127.9, 127.8, 116.2, 112.8, 52.7; IR (KBr) 3071, 2927, 2229, 1658, 1594, 1490, 1446, 1379, 1311, 1150, 1095, 1017, 972, 840, 785 cm^--1^; HRMS (EI): Calcd for C~21~H~15~ClN~2~O (M)^+^ 346.0873, found 346.0860.

### Synthesis of *N*-(2-Cyanophenyl)benzamide **6e** {#sec4.1.13}

![](ao-2019-01199f_0016){#fx7}

In a 100 mL two-necked round-bottomed flask equipped with a magnetic stirring bar, a rubber septum, a Dimroth condenser, and an argon balloon was placed benzonitrile **16** (700 mg, 2.88 mmol) in pyridine (15 mL) at room temperature, and to it was added 4-methylbenzoyl chloride (459 mg, 2.97 mmol). The reaction mixture was stirred at 80 °C for 18 h and then cooled down to room temperature. Water (10 mL) was added to quench the reaction. The mixture was extracted with ethyl acetate (80 mL). The combined organic layers were dried over sodium sulfate. The solvents were evaporated in vacuo, and then the residue was purified by column chromatography on silica gel (hexane/ethyl acetate = 10:1) and then by recrystallization from ethanol to give *N*-(2-cyanophenyl)benzamide **6e** (858 mg, 83%) as a white solid.

### *N*-(4-Chlorobenzyl)-*N*-(2-cyanophenyl)-4-methylbenzamide (**6e**) {#sec4.1.14}

Mp = 155--157 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 7.50 (d, *J* = 7.3 Hz, 1H), 7.42--7.37 (m, 1H), 7.26--7.22 (m, 7H), 6.99--6.96 (m, 3H), 5.39 (brs, 1H), 4.92 (brs, 1H), 2.24 (s, 3H); ^13^C NMR (100 MHz, CDCl~3~) δ 170.4, 145.4, 140.6, 134.7, 133.7, 133.4, 132.0, 130.5, 130.1, 128.6, 128.6, 127.6, 116.2, 112.7, 52.8, 21.3; IR (KBr) 3061, 2931, 2230, 1649, 1593, 1489, 1421, 1385, 1321, 1280, 1161, 1089, 1011, 985, 831, 793, 781, 750 cm^--1^; HRMS (EI): Calcd for C~22~H~17~ClN~2~O (M)^+^ 360.1029, found 360.1039.

### Synthesis of *N*-(2-Cyanophenyl)benzamide **6f** {#sec4.1.15}

![](ao-2019-01199f_0017){#fx8}

In a 100 mL two-necked round-bottomed flask equipped with a magnetic stirring bar, a rubber septum, a Dimroth condenser, and an argon balloon was placed benzonitrile **16** (700 mg, 2.88 mmol) in pyridine (15 mL) at room temperature, and to it was added 2-chlorobenzoyl chloride (517 mg, 2.97 mmol). The reaction mixture was stirred at 80 °C for 17 h and then cooled down to room temperature. Water (10 mL) was added to quench the reaction. The mixture was extracted with ethyl acetate (80 mL). The combined organic layers were dried over sodium sulfate. The solvents were evaporated in vacuo, and then the residue was purified by column chromatography on silica gel (hexane/ethyl acetate = 10:1) and then by recrystallization from ethanol to give *N*-(2-cyanophenyl)benzamide **6f** (617 mg, 56%) as a white solid.

### 2-Chloro-*N*-(4-chlorobenzyl)-*N*-(2-cyanophenyl)benzamide (**6f**) {#sec4.1.16}

Mp = 154--155 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 7.55--7.52 (m, 1H), 7.39--7.38 (m, 1H), 7.30--7.25 (m, 5H), 7.24--7.22 (m, 1H), 7.20--7.16 (m, 1H), 7.15--7.08 (m, 2H), 6.99--6.94 (m, 1H), 5.80 (d, *J* = 14.2 Hz, 1H), 4.53 (d, *J* = 14.2 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~) δ 166.8, 143.4, 135.4, 134.5, 134.0, 133.8, 133.7, 133.4, 130.8, 130.5, 130.2, 129.6, 128.9, 128.8, 127.9, 126.7, 116.5, 112.9, 51.8; IR (KBr) 3071, 2976, 2925, 2232, 1658, 1432, 1385, 1310, 1161, 1153, 1089, 1057, 1089, 836, 1016, 971, 797, 752 cm^--1^; HRMS (EI): Calcd for C~21~H~14~Cl~2~N~2~O (M)^+^ 380.0483, found 380.0487.

### Synthesis of *N*-(2-Cyanophenyl)benzamide **6g** {#sec4.1.17}

![](ao-2019-01199f_0018){#fx9}

In a 100 mL two-necked round-bottomed flask equipped with a magnetic stirring bar, a rubber septum, a Dimroth condenser, and an argon balloon was placed benzonitrile **16** (1.00 g, 4.12 mmol) in pyridine (20 mL) at room temperature, and to it was added 3-chlorobenzoyl chloride (738 mg, 4.24 mmol). The reaction mixture was stirred at 80 °C for 16 h and then cooled down to room temperature. Water (15 mL) was added to quench the reaction. The mixture was extracted with ethyl acetate (80 mL). The combined organic layers were dried over sodium sulfate. The solvents were evaporated in vacuo, and then the residue was purified by column chromatography on silica gel (hexane/ethyl acetate = 10:1) and then by recrystallization from ethanol to give *N*-(2-cyanophenyl)benzamide **6g** (787 mg, 50%) as a white solid.

### 3-Chloro-*N*-(4-chlorobenzyl)-*N*-(2-cyanophenyl)benzamide (**6g**) {#sec4.1.18}

Mp = 162--164 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 7.54 (d, *J* = 7.3 Hz, 1H), 7.45--7.41 (m, 1H), 7.37 (brs, 1H), 7.30--7.08 (m, 8H), 6.98 (d, *J* = 7.8 Hz, 1H), 5.38 (brs, 1H), 4.89 (brs, 1H); ^13^C NMR (100 MHz, CDCl~3~) δ 168.8, 144,7, 136.6, 134.2, 134.0, 133.8, 133.6, 130.6, 130.4, 130.2, 129.2, 128.8, 128.6, 128.2, 126.4, 116.0, 112.8, 52.8; IR (KBr) 3069, 2940, 2231, 1654, 1585, 1490, 1421, 1375, 1311, 1155, 1090, 1018, 884, 750 cm^--1^; HRMS (EI): Calcd for C~21~H~14~Cl~2~N~2~O (M)^+^ 380.0483, found 380.0485.

### Synthesis of *N*-(2-Cyanophenyl)benzamide **6h** {#sec4.1.19}

![](ao-2019-01199f_0019){#fx10}

In a 100 mL two-necked round-bottomed flask equipped with a magnetic stirring bar, a rubber septum, a Dimroth condenser, and an argon balloon was placed benzonitrile **16** (1.00 g, 4.12 mmol) in pyridine (20 mL) at room temperature, and to it was added 3,5-dichlorobenzoyl chloride (882 mg, 4.24 mmol). The reaction mixture was stirred at 80 °C for 21 h and then cooled down to room temperature. Water (15 mL) was added to quench the reaction. The mixture was extracted with ethyl acetate (80 mL). The combined organic layers were dried over sodium sulfate. The solvents were evaporated in vacuo, and then the residue was purified by column chromatography on silica gel (hexane/methanol = 10:1) and then by recrystallization from ethanol to give *N*-(2-cyanophenyl)benzamide **6h** (888 mg, 52%) as a white solid.

### 3,5-Dichloro-*N*-(4-chlorobenzyl)-*N*-(2-cyanophenyl)benzamide (**6h**) {#sec4.1.20}

Mp = 153--155 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 7.57 (d, *J* = 7.3 Hz, 1H), 7.50--7.46 (m, 1H), 7.35--7.31 (m, 1H), 7.26--7.18 (m, 7H), 7.00 (d, *J* = 7.8 Hz, 1H), 5.34 (brs, 1H), 4.89--4.86 (d, *J* = 11.6 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~) δ 167.4, 144.2, 137.6, 134.8, 134.1, 133.9, 133.8, 130.6, 130.3, 130.1, 128.8, 128.6, 126.8, 115.8, 112.8, 52.9; IR (KBr) 3073, 2943, 2226, 1651, 1595, 1565, 1491, 1384, 1313, 1224, 1166, 1104, 1016, 861, 812, 781, 749 cm^--1^; HRMS (EI): Calcd for C~21~H~13~Cl~3~N~2~O (M)^+^ 414.0094, found 414.0093.

### Synthesis of *N*-(2-Cyanophenyl)benzamide **6i** {#sec4.1.21}

![](ao-2019-01199f_0020){#fx11}

In a 100 mL two-necked round-bottomed flask equipped with a magnetic stirring bar, a rubber septum, a Dimroth condenser, and an argon balloon was placed benzonitrile **17** (1.00 g, 3.60 mmol) in pyridine (20 mL) at room temperature, and to it was added 4-chlorobenzoyl chloride (651 mg, 3.72 mmol). The reaction mixture was stirred at 80 °C for 16 h and then cooled down to room temperature. Water (15 mL) was added to quench the reaction. The mixture was extracted with ethyl acetate (100 mL). The combined organic layers were dried over sodium sulfate. The solvents were evaporated in vacuo, and then the residue was purified by column chromatography on silica gel (hexane/methanol = 10:1) and then by recrystallization from ethanol to give *N*-(2-cyanophenyl)benzamide **6i** (707 mg, 48%) as a white solid.

### 4-Chloro-*N*-(4-chloro-2-cyanophenyl)-*N*-(4-chlorobenzyl)benzamide (**6i**) {#sec4.1.22}

Mp = 138--140 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 7.52--7.45 (m, 1H), 7.43--7.38 (m, 1H), 7.31--7.19 (m, 8H), 7.00--6.92 (m, 1H), 5.30 (brs, 1H), 4.92 (brs, 1H); ^13^C NMR (100 MHz, CDCl~3~) δ 169.2, 143.5, 136.7, 134.1, 134.0, 133.9, 133.4, 133.0, 131.1, 130.5, 129.9, 128.9, 128.4, 114.8, 114.2, 52.9; IR (KBr) 3082, 2947, 2232, 1648, 1591, 1489, 1375, 1282, 1094, 1014, 970, 833, 752 cm^--1^; HRMS (EI): Calcd for C~21~H~13~Cl~3~N~2~O (M)^+^ 414.0094, found 414.0075.

### Synthesis of *N*-(2-Cyanophenyl)benzamide **6j** {#sec4.1.23}

![](ao-2019-01199f_0021){#fx12}

In a 100 mL two-necked round-bottomed flask equipped with a magnetic stirring bar, a rubber septum, a Dimroth condenser, and an argon balloon was placed benzonitrile **17** (1.00 g, 3.60 mmol) in pyridine (20 mL) at room temperature, and to it was added benzoyl chloride (581 mg, 4.13 mmol). The reaction mixture was stirred at 80 °C for 18 h and then cooled down to room temperature. Water (15 mL) was added to quench the reaction. The mixture was extracted with ethyl acetate (100 mL). The combined organic layers were dried over sodium sulfate. The solvents were evaporated in vacuo, and then the residue was purified by column chromatography on silica gel (hexane/methanol = 15:1) and then by recrystallization from ethanol to give *N*-(2-cyanophenyl)benzamide **6j** (857 mg, 62%) as a white solid.

### *N*-(4-Chloro-2-cyanophenyl)-*N*-(4-chlorobenzyl)benzamide (**6j**) {#sec4.1.24}

Mp = 128--130 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 7.46 (s, 1H), 7.36--7.20 (m, 10H), 6.89 (d, *J* = 8.2 Hz, 1H), 5.37 (brs, 1H), 4.88 (brs, 1H); ^13^C NMR (100 MHz, CDCl~3~) δ 170.3, 143.8, 134.6, 134.2, 134.0, 133.8, 133.6, 133.2, 131.4, 130.5, 128.8, 128.7, 128.4, 128.1, 114.9, 114.1, 52.8; IR (KBr) 3043, 2931, 2237, 1653, 1489, 1365, 1305, 1105, 1015, 973, 834, 784, 719 cm^--1^; HRMS (EI): Calcd for C~21~H~14~Cl~2~N~2~O (M)^+^ 380.0483, found 380.0486.

### Synthesis of *N*-(2-Cyanophenyl)benzamide **6k** {#sec4.1.25}

![](ao-2019-01199f_0022){#fx13}

To a 100 mL two-necked round-bottomed flask equipped with a magnetic stirring bar, a rubber septum, and an argon balloon were added 2-amino-5-methylbenzonitrile (700 mg, 5.30 mmol), acetic acid (20 mL), and 4-chlorobenzaldehyde (967.9 mg, 6.89 mmol). The mixture was stirred for 30 min at room temperature and cooled in an ice bath; then, NaBH~4~ (212.5 mg, 5.62 mmol) was added in portions. The resulting mixture was gradually warmed up to room temperature during 24 h. Water (20 mL) was added to quench the reaction. The mixture was extracted with ethyl acetate (100 mL). The combined organic layers were dried over sodium sulfate. The solvents were evaporated in vacuo to give the crude *N*-(2-cyanophenyl)benzamide **18** (1.69 g) as a pale yellow solid. In a 100 mL two-necked round-bottomed flask equipped with a magnetic stirring bar, a rubber septum, a Dimroth condenser, and an argon balloon was placed the crude benzonitrile **18** (1.69 g) in pyridine (20 mL) at room temperature, and to it was added 4-chlorobenzoyl chloride (1.27 g, 7.26 mmol). The reaction mixture was stirred at 80 °C for 17 h and then cooled down to room temperature. Water (15 mL) was added to quench the reaction. The mixture was extracted with ethyl acetate (100 mL). The combined organic layers were dried over sodium sulfate. The solvents were evaporated in vacuo, and then the residue was purified by column chromatography on silica gel (hexane/ethyl acetate = 10:1) and then by recrystallization from ethanol to give *N*-(2-cyanophenyl)benzamide **6k** (1.39 g, 66% (two steps)) as a pale yellow solid.

### 4-Chloro-*N*-(4-chlorobenzyl)-*N*-(2-cyano-4-methylphenyl)benzamide (**6k**) {#sec4.1.26}

Mp = 118--120 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 7.33--7.14 (m, 10H), 6.84 (d, *J* = 7.8 Hz, 1H), 5.33 (d, *J* = 12.4 Hz, 1H), 4.87 (d, *J* = 12.4 Hz, 1H), 2.29 (s, 3H); ^13^C NMR (100 MHz, CDCl~3~) δ 169.4, 142.3, 138.6, 136.2, 134.5, 134.4, 134.0, 133.8, 133.5, 130.6, 129.9, 129.8, 128.7, 128.2, 116.2, 112.4, 52.8, 20.7; IR (KBr) 3025, 2956, 2229, 1645, 1591, 1495, 1379, 1290, 1092, 1015, 970, 841, 754 cm^--1^; HRMS (EI): Calcd for C~22~H~16~Cl~2~N~2~O (M)^+^ 394.0640, found 394.0621.

### Synthesis of *N*-(2-Cyanophenyl)benzamide **10a** {#sec4.1.27}

![](ao-2019-01199f_0023){#fx14}

In a 100 mL two-necked round-bottomed flask equipped with a magnetic stirring bar, a rubber septum, a Dimroth condenser, and an argon balloon was placed benzonitrile **19**([@ref24]) (1.00 g, 4.20 mmol) in pyridine (20 mL) at room temperature, and to it was added 4-chlorobenzoyl chloride (809 mg, 4.62 mmol). The reaction mixture was stirred at 80 °C for 21 h and then cooled down to room temperature. Water (15 mL) was added to quench the reaction. The mixture was extracted with ethyl acetate (50 mL). The combined organic layers were dried over sodium sulfate. The solvents were evaporated in vacuo, and then the residue was purified by column chromatography on silica gel (hexane/ethyl acetate = 10:1) and then by recrystallization from ethanol to give *N*-(2-cyanophenyl)benzamide **10a** (585 mg, 35%) as a white solid.

### *N*-Benzyl-4-chloro-*N*-(2-cyanophenyl)benzamide (**10a**) {#sec4.1.28}

Mp = 166--168 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 7.50 (d, *J* = 7.3 Hz, 1H), 7.42--7.38 (m, 1H), 7.35--7.30 (m, 1H), 7.28--7.22 (m, 7H), 7.19--7.13 (m, 2H), 6.99 (d, *J* = 7.8 Hz, 1H), 5.44 (brs, 1H), 4.91 (brs, 1H); ^13^C NMR (100 MHz, CDCl~3~) δ 169.2, 145.1, 136.2, 135.8, 133.7, 133.6, 133.5, 130.1, 129.9, 129.1, 128.6, 128.2, 127.9, 127.9, 116.1, 112.9, 53.5; IR (KBr) 3040, 2946, 2225, 1643, 1592, 1488, 1452, 1385, 1305, 1149, 1093, 1017, 965, 756, 727, 703 cm^--1^; HRMS (EI): Calcd for C~21~H~15~ClN~2~O (M)^+^ 346.0872, found 346.0884.

### Synthesis of *N*-(2-Cyanophenyl)benzamide **10b** {#sec4.1.29}

![](ao-2019-01199f_0024){#fx15}

In a 50 mL two-necked round-bottomed flask equipped with a magnetic stirring bar, a rubber septum, a Dimroth condenser, and an argon balloon was placed benzonitrile **20**([@ref25]) (1.44 g, 9.10 mmol) in pyridine (5 mL) at room temperature, and to it was added 4-chlorobenzoyl chloride (1.64 g, 9.37 mmol). The reaction mixture was stirred at 80 °C for 14 h and then cooled down to room temperature. The reaction mixture was diluted with dichloromethane (30 mL) and washed with 2 M HCl (20 mL × 3) and saturated aqueous NaHCO~3~ solution (20 mL). The organic layers were dried over sodium sulfate and filtered. The solvents were evaporated in vacuo, and then the residue was purified by column chromatography on silica gel (hexane/ethyl acetate = 10:1) and then by recrystallization from ethanol to give *N*-(2-cyanophenyl)benzamide **10b** (2.26 g, 84%) as a white solid.

### *N*-Allyl-4-chloro-*N*-(2-cyanophenyl)benzamide (**10b**) {#sec4.1.30}

Mp = 79--81 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 7.60--7.50 (m, 2H), 7.38--7.23 (m, 4H), 7.23--7.10 (m, 2H), 6.05--5.87 (m, 1H), 5.19--5.10 (m, 2H), 4.80--4.30 (m, 2H); ^13^C NMR (100 MHz, CDCl~3~) δ 169.0, 145.3, 136.2, 133.7, 133.7, 133.5, 131.9, 129.9, 128.2, 127.9, 119.5, 116.2, 113.0, 53.4; IR (KBr) 3087, 2936, 2228, 1644, 1594, 1489, 1452, 1375, 1304, 1237, 1091, 1009, 969, 841, 754 cm^--1^; HRMS (EI): Calcd for C~17~H~13~ClN~2~O (M)^+^ 296.0716, found 296.0720.

### General Procedure for the Synthesis of 2-Aryl-4-iodoquinazolines **7** {#sec4.1.31}

In a 50 mL two-necked round-bottomed flask equipped with a magnetic stirring bar, a rubber septum, a Dimroth condenser, and an argon balloon was placed TiI~4~ (0.300 mmol) in toluene (3.0 mL) at room temperature, and to it were added TMSI (0.525 mmol) and *N*-(2-cyanophenyl)benzamide **6** (0.150 mmol). The resulting reaction mixture was stirred under reflux for 14 h and then cooled down to room temperature. The reaction mixture was quenched with phosphate buffer solution (10 mL), and EtOAc (10 mL) and 10 wt % aqueous NaHSO~3~ (10 mL) were added successively. The mixture was filtered through a celite pad and extracted with EtOAc (30 mL). The combined organic layers were washed with brine (10 mL), dried over sodium sulfate, and filtered. The solvents were evaporated in vacuo, and then the residue was purified by preparative silica gel TLC (hexane/ethyl acetate = 4:1) to give 2-aryl-4-iodoquinazoline **7**.

### 2-(4-Chlorophenyl)-4-iodoquinazoline (**7a**) {#sec4.1.32}

White solid, 47.0 mg, 85% yield. Mp = 126--128 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 8.55--8.47 (m, 2H), 7.99--7.87 (m, 3H), 7.69--7.63 (m, 1H), 7.51--7.44 (m, 2H); ^13^C NMR (100 MHz, CDCl~3~) δ 159.1, 149.7, 140.8, 137.5, 134.9, 134.9, 132.4, 130.2, 129.2, 129.0, 128.8, 128.3; IR (KBr) 3062, 1592, 1577, 1550, 1546, 1494, 1475, 1450, 1402, 1374, 1344,1301, 1297, 1239, 1167, 1088, 1013, 959, 845, 813, 788, 762, 732 cm^--1^; HRMS (EI): Calcd for C~14~H~8~ClIN~2~ (M)^+^ 365.9421, found 365.9403.

### 2-(4-Fluorophenyl)-4-iodoquinazoline (**7b**) {#sec4.1.33}

White solid, 40.7 mg, 78% yield. Mp = 109--110 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 8.61--8.56 (m, 2H), 7.98--7.87 (m, 3H), 7.66--7.62 (m, 1H), 7.22--7.16 (m, 2H); ^13^C NMR (100 MHz, CDCl~3~) δ 164.9 (d, *J* = 251 Hz), 159.1, 149.7, 140.7, 134.7, 132.5 (d, *J* = 2.9 Hz), 132.3, 130.9 (d, *J* = 8.6 Hz), 129.0, 128.6, 128.0, 115.6 (d, *J* = 22.0 Hz); IR (KBr) 3058, 1600, 1553, 1541, 1509, 1474, 1465, 1310, 1230, 1156, 957, 845, 811, 757, 736 cm^--1^; HRMS (EI): Calcd for C~14~H~8~FIN~2~ (M)^+^ 349.9716, found 349.9716.

### 2-(4-Bromophenyl)-4-iodoquinazoline (**7c**) {#sec4.1.34}

White solid, 41.6 mg, 67% yield. Mp = 138--139 °C; ^1^H NMR (400 MHz, CDCl~3~) 8.48--8.44 (m, 2H), 7.99--7.95 (m, 2H), 7.92--7.88 (m, 1H), 7.68--7.62 (m, 3H); ^13^C NMR (100 MHz, CDCl~3~) δ 159.2, 149.7, 140.7, 135.3, 134.8, 132.3, 131.8, 130.3, 129.1, 128.8, 128.2, 126.0; IR (KBr) 3071, 1551, 1536, 1475, 1449, 1395, 1302, 1239, 1172, 1072, 1009, 958, 843, 815, 788, 762, 730 cm^--1^; HRMS (EI): Calcd for C~14~H~8~BrIN~2~ (M)^+^ 409.8916, found 409.8897.

### 4-Iodo-2-phenylquinazoline (**7d**) {#sec4.1.35}

White solid, 31.2 mg, 63% yield. Mp = 130--131 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 8.60--8.55 (m, 2H), 7.98--7.93 (m, 2H), 7.89--7.85 (m, 1H), 7.64--7.60 (m, 1H), 7.55--7.50 (m, 3H); ^13^C NMR (100 MHz, CDCl~3~) δ 160.1, 149.7, 140.7, 136.3, 134.6, 132.3, 131.1, 129.1, 128.8, 128.6, 128.5, 128.1; IR (KBr) 3056, 1545, 1476, 1375, 1332, 1305, 1237, 1153, 1072, 1025, 957, 866, 812, 768 cm^--1^; HRMS (EI): Calcd for C~14~H~9~IN~2~ (M)^+^ 331.9810, found 331.9804.

### 4-Iodo-2-(*p*-tolyl)quinazoline (**7e**) {#sec4.1.36}

White solid, 29.4 mg, 57% yield. Mp = 137--139 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 8.46 (d, *J* = 8.2 Hz, 2H), 7.94--7.91 (m, 2H), 7.87--7.83 (m, 1H), 7.61--7.57 (m, 1H), 7.31 (d, *J* = 8.2 Hz, 2H), 2.43 (s, 3H); ^13^C NMR (100 MHz, CDCl~3~) δ 160.2, 149.8, 141.4, 140.6, 134.5, 133.6, 132.3, 129.4, 129.0, 128.8, 128.2, 128.0, 21.5; IR (KBr) 3033, 2913, 2854, 1606, 1555, 1475, 1306, 1240, 1175, 1152, 1114, 1062, 956, 832, 812, 785, 764, 729 cm^--1^; HRMS (EI): Calcd for C~15~H~11~IN~2~ (M)^+^ 345.9967, found 345.9951.

### 2-(2-Chlorophenyl)-4-iodoquinazoline (**7f**) {#sec4.1.37}

White solid, 32.2 mg, 59% yield. Mp = 119--121 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 8.06--8.01 (m, 2H), 7.97--7.93 (m, 1H), 7.89--7.84 (m, 1H), 7.76--7.73 (m, 1H), 7.55--7.51 (m, 1H), 7.43--7.39 (m, 2H); ^13^C NMR (100 MHz, CDCl~3~) δ 160.4, 149.1, 140.0, 136.6, 134.9, 133.2, 132.2, 131.9, 130.7, 129.4, 129.2, 128.0, 126.9; IR (KBr) 3060, 1611, 1593, 1545, 1472, 1454, 1375, 1346, 1341, 1312, 1242, 1091, 1033, 957, 868, 814, 767, 763, 745, 733 cm^--1^; HRMS (EI): Calcd for C~14~H~8~ClIN~2~ (M)^+^ 365.9421, found 365.9432.

### 2-(3-Chlorophenyl)-4-iodoquinazoline (**7g**) {#sec4.1.38}

White solid, 33.5 mg, 61% yield. Mp = 142--143 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 8.59--8.57 (m, 1H), 8.49--8.46 (m, 1H), 8.0--7.97 (m, 2H), 7.94--7.89 (m, 1H), 7.69--7.65 (m, 1H), 7.50--7.43 (m, 2H); ^13^C NMR (100 MHz, CDCl~3~) δ 158.8, 149.7, 140.8, 138.3, 134.9, 134.9, 132.4, 131.1, 130.0, 129.3, 129.0, 128.9, 128.5, 127.0; IR (KBr) 3066, 1547, 1474, 1428, 1317, 1235, 1072, 957, 780, 756, 720 cm^--1^; HRMS (EI): Calcd for C~14~H~8~ClIN~2~ (M)^+^ 365.9420, found 365.9424.

### 2-(3,5-Dichlorophenyl)-4-iodoquinazoline (**7h**) {#sec4.1.39}

White solid, 41.4 mg, 69% yield. Mp = 177--178 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 8.48--8.46 (m 2H), 8.01--7.91 (m, 3H), 7.72--7.68 (m, 1H), 7.49--7.47 (m, 1H); ^13^C NMR (100 MHz, CDCl~3~) δ 157.5, 149.4, 140.8, 139.3, 135.4, 135.0, 132.4, 130.8, 129.3, 129.2, 128.5, 127.1; IR (KBr) 3080, 1552, 1549, 1472, 1416, 1387, 1318, 1240, 1226, 959, 892, 865, 817, 800, 796, 774, 762, 727 cm^--1^; HRMS (EI): Calcd for C~14~H~7~Cl~2~IN~2~ (M)^+^ 399.9031, found 399.9035.

### 6-Chloro-2-(4-chlorophenyl)-4-iodoquinazoline (**7i**) {#sec4.1.40}

White solid, 48.4 mg, 80% yield. Mp = 183--185 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 8.52--8.48 (m, 2H), 7.98 (d, *J* = 2.3 Hz, 1H), 7.91 (d, *J* = 9.2 Hz, 1H), 7.82 (dd, *J* = 2.3, 9.2 Hz, 1H), 7.51--7.46 (m, 2H); ^13^C NMR (100 MHz, CDCl~3~) δ 159.3, 148.1, 139.0, 137.8, 135.7, 134.5, 134.4, 131.1, 130.8, 130.1, 128.9, 128.8; IR (KBr) 3078, 1545, 1535, 1467, 1408, 1286, 1079, 834 cm^--1^; HRMS (EI): Calcd for C~14~H~7~Cl~2~IN~2~ (M)^+^ 399.9031, found 399.9045.

### 6-Chloro-4-iodo-2-phenylquinazoline (**7j**) {#sec4.1.41}

White solid, 38.9 mg, 71% yield. Mp = 154--156 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 8.60--8.50 (m, 2H), 8.02--7.88 (m, 2H), 7.84--7.76 (m, 1H), 7.57--7.48 (m, 3H); ^13^C NMR (100 MHz, CDCl~3~) δ 160.4, 148.2, 138.8, 136.0, 135.6, 134.2, 131.3, 131.0, 130.9, 128.8, 128.8, 128.7; IR (KBr) 3058, 1540, 1468, 1415, 1333, 1290, 1076, 970, 823, 704 cm^--1^; HRMS (EI): Calcd for C~14~H~8~ClIN~2~ (M)^+^ 365.9421, found 365.9415.

### 2-(4-Chlorophenyl)-4-iodo-6-methylquinazoline (**7k**) {#sec4.1.42}

White solid, 28.6 mg, 50% yield. Mp = 152--154 °C; ^1^H NMR (400 MHz, CDCl~3~) δ 8.52--8.46 (m, 2H), 7.87--7.82 (m, 1H), 7.74--7.68 (m, 2H), 7.49--7.43 (m, 2H), 2.60 (s, 3H); ^13^C NMR (100 MHz, CDCl~3~) δ 158.5, 148.2, 139.9, 139.3, 137.1, 137.0, 135.0, 131.0, 129.9, 128.8, 128.1, 28.9; IR (KBr) 3078, 2922, 1542, 1490, 1408, 1336, 1309, 1235, 1172, 1166, 1086, 1011, 973, 828, 790, 726 cm^--1^; HRMS (EI): Calcd for C~15~H~10~ClIN~2~ (M)^+^ 379.9577, found 379.9586.

### Formal Synthesis of the Potent Analgesic Agent **1** {#sec4.1.43}

In a 30 mL two-necked round-bottomed flask equipped with a magnetic stirring bar, a rubber septum, a Dimroth condenser, and an argon balloon were placed 4-iodo-2-phenylquinazoline (**7d**) (20.0 mg, 0.060 mmol) and K~2~CO~3~ (10.0 mg, 0.072 mmol) in acetone (2 mL) at room temperature, and to it was added ethyl piperidine-4-carboxylate (9.5 mg, 0.060 mmol) in acetone (1 mL). The reaction mixture was stirred under reflux for 3 h and then cooled down to room temperature. Acetone was evaporated in vacuo, and then the residue was diluted with dichloromethane (30 mL), washed with H~2~O (10 mL), and then dried over sodium sulfate. The solvent was evaporated in vacuo, and then the residue was purified by preparative silica gel TLC (hexane/ethyl acetate = 1:1) to give the 2-phenylquinazoline **15** (20.4 mg, 95%) as a colorless viscous oil.

### Ethyl 1-(2-phenylquinazolin-4-yl)piperidine-4-carboxylate (**15**)^[@ref4]^ {#sec4.1.44}

^1^H NMR (400 MHz, CDCl~3~) δ 8.58--8.51 (m, 2H), 7.96 (d, *J* = 8.8 Hz, 1H), 7.87 (d, *J* = 8.4 Hz, 1H), 7.73--7.69 (m, 1H), 7.51--7.38 (m, 4H), 4.38--4.34 (m, 2H), 4.19 (q, *J* = 7.3 Hz, 2H), 3.34--3.27 (m, 2H), 2.70--2.62 (m, 1H), 2.15--1.98 (m, 4H), 1.29 (t, *J* = 7.3 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~) δ 174.5, 166.2, 159.4, 152.7, 138.6, 132.3, 130.1, 129.0, 128.4, 128.3, 124.8, 124.8, 115.5, 60.6, 49.4, 41.4, 28.1, 14.2; IR (neat) 3061, 2934, 2850, 1732, 1533, 1441, 1357, 1167, 1039, 943, 766, 709 cm^--1^; HRMS (EI): Calcd for C~22~H~23~N~3~O~2~ (M)^+^ 361.1790, found 361.1791.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.9b01199](http://pubs.acs.org/doi/abs/10.1021/acsomega.9b01199).Copies of ^1^H and ^13^C{^1^H} NMR spectra of compounds **16** (Figure S1), **17** (Figure S2), **6a--k** (Figures S3--S13), **10a** (Figure S14), **10b** (Figure S15), **7a--k** (Figures S16--S26), and **15** (Figure S27) ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01199/suppl_file/ao9b01199_si_001.pdf))
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